Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases

Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases

Abstract Background Data are limited regarding the effectiveness of omalizumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA). Our aim was to evaluate the clinical and functional effectiveness of omalizumab in patients with EGPA in long-term follow-up. Methods This study was a...

Full description

Bibliographic Details
Main Authors: Zeynep Celebi Sozener, Begum Gorgulu, Dilsad Mungan, Betul Ayse Sin, Zeynep Misirligil, Omur Aydin, Sevim Bavbek
Format: Article
Language:English
Published: Elsevier 2018-12-01
Series:World Allergy Organization Journal
Subjects:
EGPA
Churg-Strauss syndrome
Vasculitis
Asthma
Severe asthma
Omalizumab
Online Access:http://link.springer.com/article/10.1186/s40413-018-0217-0

Internet

http://link.springer.com/article/10.1186/s40413-018-0217-0

Similar Items